ALPHA-HYDROXY-BETA-OXALOSUCCINIC ACID TRISODIUM SALT
- $32 - $343
- Product name: ALPHA-HYDROXY-BETA-OXALOSUCCINIC ACID TRISODIUM SALT
- CAS: 89304-26-7
- MF: C6H3Na3O8
- MW: 272.05
- EINECS:
- MDL Number:MFCD00056721
- Synonyms:ALPHA-HYDROXY-BETA-OXALOSUCCINIC ACID TRISODIUM SALT;OXALOMALIC ACID TRISODIUM SALT;oxalomalic acid trisodium;α-hydroxy-β-oxalosuccinic acid;Oxalomalic Acid (sodium salt);α-HYDROXY-β-OXALOSUCCINIC ACID TRISODIUM SALT;SEOJXRLQAMCJON-UHFFFAOYSA-N
4 prices
Selected condition:
Brand
- Cayman Chemical
Package
- 1mg
- 5mg
- 10mg
- 25mg
- ManufacturerCayman Chemical
- Product number13521
- Product descriptionOxalomalic Acid (sodium salt) ≥95%
- Packaging1mg
- Price$32
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number13521
- Product descriptionOxalomalic Acid (sodium salt) ≥95%
- Packaging5mg
- Price$93
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number13521
- Product descriptionOxalomalic Acid (sodium salt) ≥95%
- Packaging10mg
- Price$153
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number13521
- Product descriptionOxalomalic Acid (sodium salt) ≥95%
- Packaging25mg
- Price$343
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Cayman Chemical | 13521 | Oxalomalic Acid (sodium salt) ≥95% | 1mg | $32 | 2024-03-01 | Buy |
Cayman Chemical | 13521 | Oxalomalic Acid (sodium salt) ≥95% | 5mg | $93 | 2024-03-01 | Buy |
Cayman Chemical | 13521 | Oxalomalic Acid (sodium salt) ≥95% | 10mg | $153 | 2024-03-01 | Buy |
Cayman Chemical | 13521 | Oxalomalic Acid (sodium salt) ≥95% | 25mg | $343 | 2024-03-01 | Buy |
Properties
storage temp. :−20°C
solubility :Water: 1 mg/ml
form :A crystalline solid
solubility :Water: 1 mg/ml
form :A crystalline solid
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|
Description
Aconitase catalyzes the stereospecific isomerization of citrate to isocitrate in the first step of the citric acid cycle. It acts as an iron regulatory protein (IRP), controlling the translation of proteins involved in iron metabolism when iron is scarce and resumes aconitase activity when iron is abundant. Aconitase is now recognized as a regulator of iron-induced glutamate production. Oxalomalic acid, formed by the condensation of oxaloacetate with glyoxylate in vivo, inhibits both aconitase and NADP-dependent isocitrate dehydrogenase in the conversion of citrate to isocitrate at concentrations as low as 1 mM. At 5 mM, oxalomalic acid inhibition of aconitase leads to a decrease in the binding activity of IRP1 and a decrease in glutamate secretion in cultured lens epithelial cells, retinal pigment epithelial cells, and neurons.Related product price
- 2-Ketoglutaric acid
$6-676 - Oxobutanedioic acid
$8-1430 - 3-METHYL-2-OXOVALERIC ACID
$61.6-970.2
Suppliers and manufacturers
CONIER CHEM AND PHARMA LIMITED
Shanghai Hanhong Scientific Co.,Ltd.
Shanghai EFE Biological Technology Co., Ltd.
Shanghai Hongye Biotechnology Co. Ltd
BOC Sciences
MedBioPharmaceutical Technology Inc
Shanghai Haohong Pharmaceutical Co., Ltd.
amyjetsci
Baoji Didu Pharmaceutical and Chemical Co., Ltd
TargetMol Chemicals Inc.